Wednesday, 19 August 2015

Healthcare Information System Market Study 2018

The deepening interest in integrated healthcare systems will benefit the global healthcare information systems market, leading it to achieve a compounded annual growth rate (CAGR) of 7.1% between 2013 and 2019, says Transparency Market Research in its latest report. The report, titled ‘Healthcare Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019’ states that the market, will reach US$53.2 billion by 2019, growing strongly from its 2013 value of US$35.1 billion. The growth of the market is also propelled by an increase in the healthcare costs.The other market forces pinned down by the report are: An expansion in the aging population base, supportive government initiatives, and higher investments by companies in the healthcare IT market. In contrast, aspects that will impede the growth of the healthcare information systems market are identified as: A dearth of skilled and experienced professionals, high investment and maintenance costs of healthcare informatics, and interoperability glitches.
Even as companies in the market try to address and alleviate the drawbacks of healthcare informatics, there are some remunerative opportunities that are already on the horizon. The foremost among these is wireless and cloud technology for healthcare informatics. These developments are the result of a paradigm shift from manual processes to computerized and automated processes. The burgeoning adoption of electronic health records and the growing use of mobile devices for monitoring and alerts is expected to create promising avenues for the growth of the healthcare information systems market.
An external trend that directly impacts the growth rate of the global healthcare information systems market is the increasing adoption of home health monitoring systems – the use of such systems was estimated to be 2.8 million in 2012. Wireless medical devices, too, are soon become a healthcare standard. Research studies state that in 2014, about 5.7 million patients were monitored via wireless medical devices.The report segments the healthcare information systems market by application mode as: Pharmacy information system, hospital information system, and laboratory information system. The largest among these is the hospital information systems segment, pegged to expand at a CAGR of 6.9% from 2013 to 2019. Likewise, by delivery mode, the market is classed as: On-premise technology, web-based technology, and cloud technology. The report also segments the healthcare information systems market by components as: Hardware, software, and services.
On the basis of geography, the healthcare information systems market is classified as North America, Asia, Europe, and Rest of the World (RoW).While North America is the global leader in the healthcare information systems market, Asia will report the healthiest rate of growth over the report’s forecast period, say TMR analysts. The Asian healthcare information systems market will benefit from developments in India, China, and Japan, whereas in North America, the United States will continue to fuel the market’s progress.The competitive landscape of the healthcare information systems market is still in a phase of change and growth, but is currently dominated by GE Healthcare. The other players that have an appreciable share in the market’s revenue are McKesson Corporation and Philips Healthcare.
Browse the full Healthcare Information System Market (Application Based - Hospital Information system, pharmacy Information System and Laboratory Information System Delivery Based - Web Based Technology, On-premise Technology and Cloud Based Technology Component Based- Hardware, Software and Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/healthcare-information-system.html
The global healthcare information systems market is segmented as follows:
Healthcare Information Systems Market, by application mode
  • Hospital Information System
  • Pharmacy Information System
  • Laboratory Information System
Healthcare Information Systems Market, by delivery mode
  • Web based technology
  • On-premise technology
  • Cloud based technology
Healthcare Information Systems Market, by components
  • Software
  • Hardware
  • Services
Healthcare Information Systems Market, by geography
North America
  • U.S.
  • ROW
Asia
  • Japan
  • China
Europe
  • U.K.
  • Germany
  • France
Rest of the World (RoW)
About Us:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact:
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Posted by at No comments:
Labels: , , , , , , , , ,

Pharmacy Automation Systems Market - Technologies, Trends, and Benefits

A new research study on the global market for pharmacy automation systems has been recently published by Transparency Market Research. The report, titled “Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”, states that the global market for pharmacy automation systems had a net worth of US$4.7 billion in 2011. Observing good growth at a CAGR of 7.3% over the years between 2012 and 2018, the market is anticipated to reach US$7.8 billion in 2018.
The report presents a holistic view of the global market for automated technologies converged in traditional pharmacy systems. This fusion of advanced automation technologies with the traditional pharmacy system has resulted in the occurrence of fewer medication errors, a stark reduction in medication costs, appropriate control over pharmacy inventory, and faster delivery time over the years. Rising awareness about these benefits of pharmacy automation systems in the coming years will prove to be the key driving force for the global pharmacy automation systems market. The market growth is also expected to rise due to the mounting cost pressures on healthcare providers due to regulatory pressures and reducing medical reimbursements.
The report segments the global pharmacy automation market according to three chief criteria: types of automation systems based on technology, key end users, and key regional markets. The typical pharmacy processes and systems automated in the market, covered by the report, include automated dispensing systems, storage and retrieval systems, automated packaging and labeling, automated compounding systems, and table-top counters. Of these, the market for the segment automated medication dispensing systems held nearly 48% share of the market in 2011, the largest among all other automation systems studied by the report. Revenue generated by this market segment was nearly US$2.3 billion in the same year. The report states that this market segment will grow at a CAGR Of 6.7% over report’s forecast, and reach US$3.6 billion by 2018.
Of the key end users of the global pharmacy automation system studied by the report, hospital pharmacies and retail pharmacies, the market earns a major portion of its revenues from hospital pharmacies, especially the ones located in large hospitals with more than 400 beds. A rising trend of decentralized or hybrid pharmacies is considered a chief factor leading to increased demand for pharmacy automation systems from the hospital pharmacy segment. However, the high deployment costs of these systems have led to reluctant demand from some emerging economies.
The healthcare industry of North America, usually the fist adopter of novel technologies, currently accounts for over half of the overall share of the global pharmacy automation market.
Browse the full Pharmacy Automation Systems Market (Table-Top Counters, Medication Dispensing, Packaging and Labelling, Storage, Retrieval and Compounding) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/pharmacy-automation-systems.html
The market features several emerging as well as established players in the sections of different automation technologies and solutions. CareFusion Corp., currently dominates the global pharmacy automation systems market while Kirby Lester is the chief provider of automated table-top counter systems. Other key businesses operating in the marketplace include McKesson Corp, Swisslog Holding Ltd., AmerisourceBergen Corp, Omnicell Inc, Health-Robotics S.R.L, and ScriptPro.
Posted by at No comments:
Labels: , , , , , , , ,

Healthcare Cloud Computing Market is Highly Fragmented But Expected to Register Exponential Growth at 21.3% CAGR

As healthcare organizations explore means to counter the escalating costs of delivering their services to patients, cloud computing has emerged as a viable solution to the problem. The global cloud computing market is thus poised to witness unprecedented interest from the healthcare services sector, and will register a CAGR of 21.3% between 2012 and 2018, finds a report by Transparency Market Research (TMR). The report, titled ‘Cloud Computing Market - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018’, estimates cloud computing in the healthcare industry to be a US$ 6.79 billion market by 2018. The market was valued at US$ 1.82 billion in 2011.
The pressure on healthcare service providers to deliver optimal level of care while maintaining a balance between speed and costs has created the perfect setting for the growth and expansion of the healthcare cloud computing industry. Healthcare service providers expect attributes such as bulk data management, accurate information retrieval, optimal efficiency and security from healthcare cloud computing services providers. Cloud computing enables healthcare organizations to access, and share information stored across disparate platforms, including mobile devices. It is for these reasons that the cloud computing market in the healthcare industry will witness high growth in the years to come.
The healthcare cloud computing market is fragmented because of the sheer number of players operating in this market. No single player has a share exceeding 5%-10%, the report finds. Moreover, the unique dynamics of this market on the demand side necessitate the deployment of customized solutions for each establishment. This further prevents the industry from reaching standardization. Some of the healthcare cloud computing providers that have a significant share in market revenues are: CareCloud, Merge Healthcare, ClearDATA Networks, Agfa Healthcare, Microsoft, IBM Corporation, and Oracle Corporation.
TMR’s report notes that the North American healthcare cloud computing market held the largest shares globally in 2011, and it is also the fastest growing market globally. In 2011, Europe and Asia followed closely behind the North America region.
Going forward, the report notes that with more and more organizations phasing out investments in physical IT infrastructure, the demand for cloud-based healthcare services will see a parallel rise. The most popular service model in cloud computing in the healthcare industry will be that of Platform-as-a-Service (PaaS). Furthermore, this report studies the markets for private, public and hybrid cloud services in detail.
Browse the full Cloud Computing Market In Healthcare Industry (IAAS, SAAS, PAAS, CIS, NCIS, PACS, EMR, RIS) - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018 report at http://www.transparencymarketresearch.com/healthcare-cloud-computing.html
The report studies the following sub segments under service models in the healthcare cloud computing market: Platform as a Service (PaaS), Infrastructure as a Service (IaaS), and Software as a Service (SaaS). Of these, the former will see the highest growth thanks to its desirable attributes such as simplified application and ease of deployment. Moreover, PaaS doesn’t need to extensively rely on software or hardware and it provides support through the entire life cycle of the web application.
Posted by at No comments:
Labels: , , , , , , , ,

Monday, 17 August 2015

What experts are saying about Patient Registry Software Market

A patient registry is a structured system that uses experimental study methods to gather and and stock patient information to estimate detailed outcomes for a specific set of population defined by a particular condition, disease, or drug or medical device exposure. Patient registry software has made it effortless for healthcare agencies, pharma industry, medical centers and universities to perform clinical studies. These studies help them to gather data and understand medical results of the patients.
Patient registry software is used for rapid collection of patient’s data from one or various locations. Apart from data collection it creates an information repository i.e. pulling data from third party systems and storing them. It also monitors the trends and improves health outcomes for the patients.
The patient registry software market is segmented on the basis of delivery model, functionality, database type, product type, and end user.
On the basis of delivery model, the global patient registry software market is categorized into:
Subscription models – includes cloud based delivery modes
Ownership models- It includes On-premise mode of delivery
The subscription model is the highly used patient registry software type as it enhances the quality of patient care by measuring performance parameters for quality improvement programs, resulting in higher-quality care.
On the basis of product type, the global patient registry software market is categorized into following types:
Integrated software
Standalone software.
The acceptance rate of integrated software is more as they are user-friendly and unified with different functionalities such as patient demographics, insurance details, medical history, pharmacy and others thereby reducing the overall cost of healthcare.
Further, on the basis of database type, the global patient registry software market is analyzed into:
diabetes
heart diseases
tumors
rare disease/orphan disease
chronic conditions and other registries
The rare disease registries are expected to experience higher growth due to increasing pool of patients for these diseases.
The global patient registry software market is driven by various factors including:
Rising pressure on healthcare organizations to enhance the quality of care and reduce the cost of healthcare and increased acceptance of electronic health records (EHR). Electronic health records improve quality and convenience of patient care. Providers can make efficient and effective therapeutic decisions about patient care through analysis, clinical alerts and reminders, based on the recorded patient information.
Government initiatives for population health management To maintain the use of electronic health records, the American Recovery and Reinvestment Act provides resources to:
Assist health care providers to make use of electronic health records to increase quality, effectiveness and population health outcomes of health care.
Provides training for careers in healthcare information technology that will help health care providers to put into practice electronic health records.
Federal health IT policy will continually focus on improving the outcomes of care, so as to advance the performance of their health care system.
Geographically, the global patient registry software market is segmented into North America, Europe, Asia Pacific and Rest of the World. Subscription (cloud based delivery modes) models, integrated software, and rare/orphan diseases registries are expected to fuel the patient registry software market during the forecast period. End user includes hospitals, government organizations and third party administrators who use this software for public health management, and improve the quality of patient care.

Some of the key global market participants present in the global patient registry software market include Telligen, Inc., ifa systems AG, Image Trend, Inc., INC Research holdings, Inc., Phytel, Inc., Optum, Inc., Global Vision Technology, Velos, Inc., and McKesson Corporation.
Posted by at No comments:
Labels: , , , , , ,

Herpes Marker Testing Market - Industry Overview and Key Factors

Herpes virus is a ubiquitous pathogen whose primary infections are usually asymptomatic. There are two types of Herpes Simplex virus (HSV): HSV-1 is known to cause orofacial disease such as cold sores; while HSV-2 causes genital infections. Over 80% of the herpes infections are asymptomatic; symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. Period of latency and mode of reactivation of HSV is yet unclear.
Herpes Simplex is a highly contagious virus which is passes through direct contact with infected patients. The virus is transferred through body fluids such as saliva, blood and semen. Some studies have also shown that the virus can be transferred through breast milk. HSV infection is also common in patients with compromised immune system. Thus transplant patients and human immunodeficiency virus (HIV) positive patients are at higher risk of acquiring HSV infections. Since majority of HSV infections are asymptomatic, physicians are dependent on diagnostic tests for accurate diagnosis and treatment. Currently, there are four types of tests available for HSV biomarker testing; these include cell culture tests, antigen tests, antibody tests, and polymerase chain reaction (PCR) tests. In cell culture tests, specimens from the skin lesions or blisters are taken to develop viral cultures. Although the test is more accurate, it is time consuming and may give false negative results if lesions are in process of healing. Antigen and antibody tests are enzyme linked Immunosorbent assay (ELISA) based tests and are the most widely used tests globally. Blood samples are usually tested for HSV antigens and antibodies. These rapid tests provide quick and accurate results, which helps in further diagnosis and treatments. PCR tests have been the most accurate tests used for HSV diagnosis. The test can also differentiate between HSV-1 and HSV-2 viral load.
According to prevalence statistics published by Centers for Disease Control and Prevention (CDC), HSV-2 prevalence was found to be over 16% in the U.S. citizens and mainly affected African-America female population. Public Health Agency of Canada mentions that prevalence of HSV-1 infection is greater than HSV-2 infections is most of the geographical regions. The data also shows that HSV-1 seroprevalence in adults in over 70% in developed countries, while almost 100% in developing and underdeveloped countries. Various publications also show that prevalence of HIV is higher in low and middle income countries. Thus it is expected that the prevalence of herpes simplex virus would remain high in these countries. Due to under developed economic conditions, cost effective diagnosed tests are in high demand. In spite of these conditions, North America and Europe lead the market owing to higher seroprevalence, and large number of transplant and HIV patients.
In 2014, U.S. FDA approved Quest Diagnostics, Inc’s HSV diagnostic test Simplexa HSV 1 and 2 direct molecular test on the 3M Integrated Cycler. The Simplexa test is the first molecular test that has been approved by the U.S. FDA, that enables qualitative detection as well as differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF). Other diagnostic tests in the market include Capita IgG test by Trinity Biotech, IsoAmp HSV Assay by Biohelix and HerpeSelect by Focus Diagnostics. Some of the key players in the global herpes marker testing market include DiaSorin, Roche, Enzo Life Sciences and Thermo Fisher Scientific.
Posted by at No comments:
Labels: , , , , , ,

Global Report on Wireless Health Market

The e-health monitoring system with wireless sensor network is used for patient telemonitoring and telemedicine. A 2012 article titled ‘In-home health monitoring to leap six-fold by 2017’ illustrated that Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in the next four years. Of the billions of dollars spent on health care each year, 75% - 80% of it accountsfor patients with chronic illnesses such as diabetes, heart disease, asthma and Alzheimer’s disease. Over a decade, healthcare industry has taken a measured approach pertaining tointegrationof information technology (IT). Recent federal legislation and emerging trends, however, are changing the landscape and driving the need to accelerate the adoption of health IT in healthcare especially in medical devices.
Among wireless health products wearable medical devices is expected to be the fastest growing segment. Information delivered by modern wearable medical devices is easy to interpret and hence popularity is expected to increase rapidly within non-medical personnel. With these devices, peoplecan quickly modify their lifestyle to better improve their physical stature. Devices that measure temperature, heart rate and other parameters can be of paramount importance while determining physical fitness of a person.Over 65% of technologies are wrist held devices shaped like watches and the rest are wearable on other areas of the body such as arms, torso and waist. Along with the aesthetics, several other features for durability of the device are included such as waterproofing and weatherproofing. The latest in developments is telecommunication, wireless connectivity and improved user interface. The advent of smartphones has resulted in multi-fold increase of growth in applications that can now extend to storage and retrieval of history for the individual for long term mapping and improvement of fitness.
Some of the major factors driving this market are the decreasing costs of electronics that has now made these devices available to middle and even low income groups over the world, and increased use of internet globally. According to the World Bank, number of internet users per 100 people increased from 15.8 in 2005 to 38.1 in 2013. The global wireless health market by products encompasses ECG monitors, insulin monitors, neuromonitors such as EEG and EMG devices.There are several devices which have in-build capability to diagnose, detect and send patient records to a centralized servers which can be easily accessed by healthcare providers. Advantages of wireless health devices encompasses patient comfort, accurate detection and analysis, access to stored patient data for a considerable longer period of time i.e. weekly or monthly. Recently Engineers at the University of Illinois at Urbana-Champaign and Northwestern University have demonstrated stick-on patches which can be used on a daily basis to monitor patient’s ECG. Additionally, the patient record can be easily accessed through a cell phone or computer wirelessly.
Geographically the market can be studied for four geographical regions: North America, Europe, Asia Pacific and Rest of the Word. Currently, North America in terms of revenue accounts for the largest share owing to burgeoning population of cardiovascular diseases, diabetic patients. Moreover government initiatives such as the Affordable Care Act and favorable reimbursement scenario also promotes the sales and adoption of innovative wireless health monitoring and diagnostic products. Followed by the U.S., Europe holds the second leading position in the current scenario. Historically, the major EU countries have always been at the forefront of developing innovative healthcare technologies.In November 2013, Belgium-based research center Imec showcased its ideas for wearable sensor technologies for remote healthcare and personal health applications. The company introduced a body patch that integrates an ultra-low power electrocardiogram (ECG) chip and a Bluetooth low-energy radio. The company has also developed a prototype of a patient-friendly wireless EEG headset together with Holst Centre and Panasonic. Asia Pacific and Rest of the World market are among the fastest growing and largely untapped market. High cost of devices and lack of awareness about these devices are among the major restraint to the current adoption of the products in emerging market.
Some of the key players operating in this market encompasses Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Polar Electro, Nihon Kohden, Siemens A.G., Mckesson Corporation,and Cerner Corporation.
Posted by at No comments:
Labels: , , , , , ,

Forecasts of growth in the Health Care Social Media Marketing Market

Social media is a virtual platform in which people interact, create and share content, information, ideas and views using online tools and related networks. Social media marketing is a process of achieving network attention with the help of social media platforms. Social media is building connections between end users and service providers by providing relatively simple, easy to access and unbiased platforms for sharing feedback. Social media interactions are integral part of marketing and customer service relations in any industry, hence social media in healthcare industry is no exception. Heath care organizations and health care personnel have started considering social media as an important tool for connecting with the end-users and keeping the consumers updated about the product development. The increasing number of consumers using social media for accessing and seeking information related to health care issues is acting as the driving force towards the progress of the health care social media marketing market. As well as, healthcare professionals and service providers are seeking global social media websites such as Facebook, Twitter, Google plus and others as a networking platform. This would enable them to gain end users trust with easily accessible healthcare information and ultimately assisting the market growth. Increased expenditure on web advertisement by health care companies is also a factor propelling the market growth. However, there is an inherent risk correlated to social media marketing in healthcare making its usage a debatable subject. All the information available on internet is not authentic, making it vulnerable for creating mistrust among the users. Similarly, privacy is also susceptible factor while associating and engaging with patients via social media. These factors act as a challenging aspect for the health care social media marketing market.
Today’s generation is extremely tech oriented and health conscious as well as the concerned for the health of their family. As a result, people are seeking for information and interacting with the health care industry by the means of web forum like never before. On the other hand, social media is providing a cost-effective and reasonable platform for the health care industry to reach out to the prospective consumers, making it as the best suited forum for the transparent communication. The participation of regulatory authorities in the issues related to drafting the guidelines for the health care organization regarding the use of interactive media for the biologics and drugs has proven to be contributory factor for the use of social media marketing for healthcare. As per U.S. Food and Drug Administration (FDA), the pharma companies can promote their product and on the third party sites such as Facebook, Twitter, LinkedIn, etc. and the firm is responsible for the product promotional activities on the sites. While getting feedbacks from the customers is important, the organization shall also incorporate these feedbacks into their business and business strategies in a meaningful manner is equally important. While some organizations have taken the lead in this area, many others are struggling to understand this new medium of opportunity. Novartis has enhanced the sales of their over the counter products by promoting it on social media forum. Similarly, Johnson and Johnson have utilized social media for idea generation and in crises management.
Geographically, North America has the largest market for the health care social media marketing market, followed by Europe, due to large pool of tech savvy consumers. According to a study, Almost 72 % of patients searched for online information before or after a doctor visit. Moreover, the pharma giants taking up social media for the interaction are majorly based in this region. Asia Pacific is the most attractive market for the health care social media marketing market due to increasing number of internet users and developing technological interface in the countries such as Japan, China, India and Australia. Rest of the world has a potential for the growth as there are untapped opportunities in the health care social media marketing market.
Developing a social media platform is no more an option today, it is a necessity. Some of the major players engaging in the health care social media marketing are Bayer AG, Johnson & Johnson, Inc., Novartis AG, Novo Nordisk AS, and Pfizer, Inc.
Posted by at No comments:
Labels: , , , , , ,

Global Factors and Perspective of the Kidney Function Tests Market

Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Since, kidneys play such an important role, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, due to which they are vulnerable to cancerous tumorsandmetastasis. The functional damage of the kidney isastoundingly common across the world, and its incidence is increasing progressively more. The symptoms which indicates a problem related to kidneys include high blood pressure, blood in urine,difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.


Kidney function tests, or renal tests have several categories, which includes concentration and dilution tests, clearance tests (provides an assessment of the filtration rate of the glomeruli, the principal filtering structures of the kidneys and whole renal blood flow),visual and physical examination of the urine, and determination of the concentration of numerous substances in the urine, notably glucose, phosphate, sodium, amino acids, and potassium, to help detect possible impairment of the specific kidney functions generally involved with their reabsorption.
Geographically, the global kidney function testsmarket is analyzed by various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Rest of the World. North America dominates the global kidney function tests market followed by Europe due to high prevalence of the disease especially in the U.S., well-established healthcare infrastructure, and high affordability and awareness levels of the people of these regions.Asia Pacific is the fastests growing kidney function testsmarket owing to increasing number of high blood pressure and diabetic patients that ultimately lead to chronic kidney diseases, rising healthcare awareness in the region and increasing demand for advanced diagnostics and therapeutics regimens for chronic kidney diseases in the region, are expected to boost market growth of kidney function tests in this region.
Globally, the factors driving the growth of kidney function tests market include increasing incidences and prevalence of chronic kidney disease worldwide, aging population,high incidence rate of renal fibrosis, and increasing number of individuals suffering from diabetes. Also, other complications such as high blood pressure is contributing towards the increasing incidence rate and prevalence of chronic kidney disease worldwide.Demand for kidney function tests is mainly driven by the presence of a large patient population suffering from renal disorders. According to the WHO, there are more than 1.4 million people worldwide, who undergo renal replacement therapy every year with the incidence rate of chronic kidney disease growing by approximately 8% annually.However, increase in overall stringent regulatory approvals and healthcare expenditure are some of the market-restraining factors that might hamper the growth of the kidney function tests market in future.


The global kidney function tests market is highly competitive and mature due to the participation and presence of many established as well as new players in this market.Some of the key global participants present in the kidney function tests market include F. Hoffmann-La Roche Ltd , Metabolic Solutions Development Company, LLC, Galectin Therapeutics, Inc., Baxter International Inc., Discovery Biomed, Inc., Otsuka Holdings Co., Ltd., Kadmon Corporation, LLC, Ipsen S.A., Eli Lilly and Company, Plexxikon Inc., IC-Meditech, Inc., Endocyte, Inc., ManRos Therapeutics, Pfizer Inc. and others.

Posted by at No comments:
Labels: , , , , , ,
Subscribe to: Comments (Atom)